Returning to its home-ground in Boston, the 12^th World CB & CDx Summit is back at a pivotal time for precision medicine! Join your dedicated community as we explore biomarker discovery through to commercialization alongside a diagnostic to deliver safe and effective precision & targeted therapies to more patients with maximised global access.

Across 2 days and 3 tracks, 70+ diverse industry stakeholders will address the most important challenges, technological innovations and pipeline updates to support the community in bringing the next generation of Drug-Dx development to the hands of patients.

From next-generation biomarker discovery & validation, the latest clinical multi-biomarker & AI-based stratification strategies, advances in liquid biopsy validation through to critical U.S FDA CRRH & CDER, IVDR & APAC regulatory updates, you cannot afford to miss this crucial date in the precision medicine industry calendar in 2022.

Stay ahead of the biomarker and CDx adoption strategy curve and lay the foundation of a speedy approval and launch excellence to deliver a breakthrough therapy for patients worldwide!